These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9635211)

  • 41. Self-reported empathy deficits are uniquely associated with poor functioning in schizophrenia.
    Smith MJ; Horan WP; Karpouzian TM; Abram SV; Cobia DJ; Csernansky JG
    Schizophr Res; 2012 May; 137(1-3):196-202. PubMed ID: 22321668
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural brain abnormalities in first-episode psychosis: differences between affective psychoses and schizophrenia and relationship to clinical outcome.
    de Castro-Manglano P; Mechelli A; Soutullo C; Landecho I; Gimenez-Amaya JM; Ortuño F; McGuire P
    Bipolar Disord; 2011; 13(5-6):545-55. PubMed ID: 22017223
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The facial expression of schizophrenic patients applied with infrared thermal facial image sequence.
    Jian BL; Chen CL; Chu WL; Huang MW
    BMC Psychiatry; 2017 Jun; 17(1):229. PubMed ID: 28646852
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neurochemical psychiatry as a source of hypotheses concerning the role of homeostatic mechanisms in brain function.
    Richardson JS
    Int J Neurosci; 1984 Nov; 24(3-4):197-202. PubMed ID: 6150904
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biochemical theories of schizophrenia and depression.
    Hollister LE
    Ann Acad Med Singap; 1985 Jan; 14(1):76-80. PubMed ID: 4039908
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Contrasts in neuropsychological test profile between patients with first-episode schizophrenia and first-episode affective disorders.
    Albus M; Hubmann W; Wahlheim C; Sobizack N; Franz U; Mohr F
    Acta Psychiatr Scand; 1996 Aug; 94(2):87-93. PubMed ID: 8883568
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Psychobiology and psychosocial functioning of schizoaffective disorder.
    Correll CU
    J Clin Psychiatry; 2011 Feb; 72(2):e05. PubMed ID: 21382300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Brain imaging in schizophrenia.
    Kotrla KJ; Weinberger DR
    Annu Rev Med; 1995; 46():113-22. PubMed ID: 7598448
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Awareness of illness in schizophrenia and schizoaffective and mood disorders.
    Amador XF; Flaum M; Andreasen NC; Strauss DH; Yale SA; Clark SC; Gorman JM
    Arch Gen Psychiatry; 1994 Oct; 51(10):826-36. PubMed ID: 7944872
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Informed consent and neuroanatomic correlates of intentionality and voluntariness among psychiatric patients.
    Grimes AL; McCullough LB; Kunik ME; Molinari V; Workman RH
    Psychiatr Serv; 2000 Dec; 51(12):1561-7. PubMed ID: 11097654
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Brain imaging: applications in psychiatry.
    Andreasen NC
    Science; 1988 Mar; 239(4846):1381-8. PubMed ID: 3279509
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Diagnostic criteria for research in psychiatry (RDC) and guide for the diagnosis of affective disorders and schizophrenia (SADS)].
    Charles G; Ansseau M
    Acta Psychiatr Belg; 1990; 90(5-6):225-38. PubMed ID: 1670401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional neuroimaging of sleep.
    Nofzinger EA
    Semin Neurol; 2005 Mar; 25(1):9-18. PubMed ID: 15798933
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Procedural validity of an abbreviated version of the SADS/RDC diagnostic process.
    Green RL; Price TR
    Psychiatry Res; 1986 Aug; 18(4):379-91. PubMed ID: 3749394
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurological soft signs discriminating mood disorders from first episode schizophrenia.
    Boks MP; Liddle PF; Burgerhof JG; Knegtering R; van den Bosch RJ
    Acta Psychiatr Scand; 2004 Jul; 110(1):29-35. PubMed ID: 15180777
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Component structure of the expanded Brief Psychiatric Rating Scale (BPRS-E).
    Dingemans PM; Linszen DH; Lenior ME; Smeets RM
    Psychopharmacology (Berl); 1995 Dec; 122(3):263-7. PubMed ID: 8748395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical studies implementing glutamate neurotransmission in mood disorders.
    Sanacora G; Rothman DL; Mason G; Krystal JH
    Ann N Y Acad Sci; 2003 Nov; 1003():292-308. PubMed ID: 14684453
    [TBL] [Abstract][Full Text] [Related]  

  • 58. What have we learned from functional imaging studies in schizophrenia? The role of frontal, striatal and temporal areas.
    Velakoulis D; Pantelis C
    Aust N Z J Psychiatry; 1996 Apr; 30(2):195-209. PubMed ID: 8811262
    [TBL] [Abstract][Full Text] [Related]  

  • 59. GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum.
    Fatemi SH; Stary JM; Earle JA; Araghi-Niknam M; Eagan E
    Schizophr Res; 2005 Jan; 72(2-3):109-22. PubMed ID: 15560956
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Magnetic resonace imaging study in major psychiatric disorders.
    Lalitanantpong D; Lalitanantpong S
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S300-8. PubMed ID: 16083207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.